Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study

American Journal of Psychiatry

Volumn 171, Issue 5, 2014, Pages 572-581

  Geda, Yonas E ^a,b,c,d,e   Roberts, Rosebud O ^a,b,c,d,e   Mielke, Michelle M ^a,b,c,d,e   Knopman, David S ^a,b,c,d,e   Christianson, Teresa J H ^a,b,c,d,e   Pankratz, Vernon S ^a,b,c,d,e   Boeve, Bradley F ^a,b,c,d,e   Sochor, Ondřej ^a,b,c,d,e   Tangalos, Eric G ^a,b,c,d,e   Petersen, Ronald C ^a,b,c,d,e   Rocca, Walter A ^a,b,c,d,e  

^a Health Sciences Research   (United States)

^b MAYO CLINIC   (United States)

^c Departments of Psychiatry and Psychology   (United States)

^d MAYO CLINIC   (United States)

^e ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; AGITATION; ANXIETY; APATHY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE CLASSIFICATION; DISINHIBITION; EUPHORIA; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC INVENTORY QUESTIONNAIRE; NEUROPSYCHIATRIC SYMPTOM; NIGHTTIME BEHAVIOR; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; AGING; ANXIETY; APATHY; COGNITION; DEPRESSION; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; IRRITABLE MOOD; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; RISK;

EID: 84899724518     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.13060821     Document Type: Article

References (52)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303-308
2. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR Jr, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ; Alzheimer's Disease Cooperative Study: Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004; 61:59-66
3. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group: Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352:2379-2388
4. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST; Report of the Quality Standards Subcommittee of the American Academy of Neurology: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology 2001; 56:1133-1142
5. Richard E, Schmand B, Eikelenboom P, Yang SC, Ligthart SA, Moll van Charante EP, van Gool WA; Alzheimer's Disease Neuroimaging Initiative: Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects. Dement Geriatr Cogn Disord 2012; 33:204-209
6. Mitchell RA, Herrmann N, Lanctôt KL: The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. CNS Neurosci Ther 2011; 17:411-427
7. Palmer K, Di Iulio F, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Spalletta G: Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. J Alzheimers Dis 2010; 20:175-183
8. Rosenberg PB, Mielke MM, Appleby B, Oh E, Leoutsakos JM, Lyketsos CG: Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry 2011; 26:364-372
9. Ramakers IH, Visser PJ, Aalten P, Kester A, Jolles J, Verhey FR: Affective symptoms as predictors of Alzheimer's disease in subjects with mild cognitive impairment: a 10-year follow-up study. Psychol Med 2010; 40:1193-1201
10. Geda YE, Knopman DS, Mrazek DA, Jicha GA, Smith GE, Negash S, Boeve BF, Ivnik RJ, Petersen RC, Pankratz VS, Rocca WA: Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol 2006; 63:435-440
11. Wilson RS, Schneider JA, Boyle PA, Arnold SE, Tang Y, Bennett DA: Chronic distress and incidence of mild cognitive impairment. Neurology 2007; 68:2085-2092
12. Brodaty H, Heffernan M, Draper B, Reppermund S, Kochan NA, Slavin MJ, Trollor JN, Sachdev PS: Neuropsychiatric symptoms in older people with and without cognitive impairment. J Alzheimers Dis 2012; 31:411-420
13. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Ivnik RJ, Tangalos EG, Petersen RC, Rocca WA: The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 2008; 30: 58-69
14. Petersen RC, Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Rocca WA; The Mayo Clinic Study of Aging: Prevalence of mild cognitive impairment is higher in men. Neurology 2010; 75:889-897
15. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Rocca WA, Petersen RC: The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology 2012; 78:342-351
16. St Sauver JL, Grossardt BR, Yawn BP, Melton LJ, Rocca WA: Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol 2011; 173:1059-1068
17. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412-2414
18. Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC: The Short Test of Mental Status: correlations with standardized psychometric testing. Arch Neurol 1991; 48:725-728
19. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC, Kokmen E, Kurland LT: Mayo's Older Americans Normative Studies: WAIS-R norms for ages 56 to 97. Clin Neuropsychol 1992; 6: 1-30
20. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC, Kokmen E, Kurland LT: Mayo's Older Americans Normative Studies: WMS-R norms for ages 56 to 94. Clin Neuropsychol 1992; 6: 49-82
21. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC, Kokmen E, Kurland LT: Mayo's Older Americans Normative Studies: updated AVLT norms for ages 56 to 97. Clin Neuropsychol 1992; 6:83-104
22. Malec JF, Ivnik RJ, Smith GE, Tangalos EG, Petersen RC, Kokmen E, Kurland LT: Mayo's Older Americans Normative Studies: utility of corrections for age and education for the WAIS-R. Clin Neuropsychol 1992; 6:31-47
23. Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8:271-276
24. Kaplan E, Goodglass H, Brand S: Boston Naming Test. Philadelphia, Lea and Febiger, 1983
25. Lucas JA, Ivnik RJ, Smith GE, Bohac DL, Tangalos EG, Graff-Radford NR, Petersen RC: Mayo's older Americans Normative Studies: category fluency norms. J Clin Exp Neuropsychol 1998; 20:194-200
26. Ivnik R, Malec J, Smith G, Tangalos E, Petersen R, Kokmen E, Kurland L: Mayo's Older Americans Normative Studies: WAIS-R, WMS-R, and AVLT norms for ages 56 through 97. Clin Neuropsychol 1992; 6:1-104
27. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256:183-194
28. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246
29. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
31. Geda YE, Roberts RO, Knopman DS, Petersen RC, Christianson TJ, Pankratz VS, Smith GE, Boeve BF, Ivnik RJ, Tangalos EG, Rocca WA: Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry 2008; 65:1193-1198
32. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST: Validation of the NPI-Q: a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000; 12:233-239
33. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
34. Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA: The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006; 20:210-216
35. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383
36. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-619
37. Hölttä EH, Laakkonen M-L, Laurila JV, Strandberg TE, Tilvis RS, Pitkälä KH: Apathy: prevalence, associated factors, and prognostic value among frail, older inpatients. J Am Med Dir Assoc 2012; 13:541-545
38. Schreiner AS: Aggressive behaviors among demented nursing home residents in Japan. Int J Geriatr Psychiatry 2001; 16: 209-215
39. Steffens DC, Norton MC, Hart AD, Skoog I, Corcoran C, Breitner JC; Cache County Study Group: Apolipoprotein E genotype and major depression in a community of older adults. The Cache County Study. Psychol Med 2003; 33:541-547
40. Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG: Sex and depression in the National Comorbidity Survey, II: cohort effects. J Affect Disord 1994; 30:15-26
41. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:617-627
42. Kantarci K, Weigand SD, Przybelski SA, Preboske GM, Pankratz VS, Vemuri P, Senjem ML, Murphy MC, Gunter JL, Machulda MM, Ivnik RJ, Roberts RO, Boeve BF, Rocca WA, Knopman DS, Petersen RC, Jack CR Jr: MRI and MRS predictors of mild cognitive impairment in a population-based sample. Neurology 2013; 81:126-133
43. Luck T, Riedel-Heller SG, Luppa M, Wiese B, Wollny A, Wagner M, Bickel H, Weyerer S, Pentzek M, Haller F, Moesch E, Werle J, Eisele M, Maier W, van den Bussche H, Kaduszkiewicz H; Age-CoDe Study Group: Risk factors for incident mild cognitive impairment: results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). Acta Psychiatr Scand 2010; 121:260-272
44. Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R: Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain 2010; 133: 540-556
45. Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG: The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry 2013; 21:685-695
46. Brodaty H, Heffernan M, Kochan NA, Draper B, Trollor JN, Reppermund S, Slavin MJ, Sachdev PS: Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study. Alzheimers Dement 2013; 9:310-317
47. Bienias JL, Beckett LA, Bennett DA, Wilson RS, Evans DA: Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis 2003; 5:349-355
48. Costa PT Jr, McCrae RR: Personality in adulthood: a six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. J Pers Soc Psychol 1988; 54:853-863
49. Geda YE, Schneider LS, Gitlin LN,Miller DS, Smith GS, Bell J, Evans J, Lee M, Porsteinsson A, Lanctot KL, Rosenberg PB, Sultzer DL, Francis PT, Brodaty H, Padala PP, Onyike CU, Ortiz LA, Ancoli-Israel S, Bliwise DL, Martin JL, Vitiello MV, Yaffe K, Zee PC, Herrmann N, Sweet RA, Ballard C, Khin NA, Alfaro C, Murray PS, Schultz S, Lyketsos CG; Neuropsychiatric Syndromes Professional Interest Area of ISTAART: Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement 2013; 9:602-608
50. Kokmen E, Ozsarfati Y, Beard CM, O'Brien PC, Rocca WA: Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. J Clin Epidemiol 1996; 49:79-83
51. Tsuang D, Kukull W, Sheppard L, Barnhart RL, Peskind E, Edland SD, Schellenberg G, Raskind M, Larson EB: Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples. J Am Geriatr Soc 1996; 44:704-707
52. Szklo M, Nieto FJ: Epidemiology: Beyond the Basics, 2nd ed. Sudbury, Mass, Jones and Bartlett, 2007